A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. - Ruperto,N.; Murray,KJ.; Gerloni,V. (Arthritis Rheum, 2004)